Find out where you are as it relates to international arbitration in the life sciences space, by taking our brief survey.
Results will be emailed to you after all survey responses have been received.
Why We Need Your Responses
We want to better understand concerns and issues the industry is facing and to be more effective in addressing these concerns. Additionally, we want to identify industry trends and potentially predict legal issues before they impact your business. In short, we want to be better lawyers.
Why Should You Care
As an industry professional, it’s important to stay on top of the latest trends and stay ahead of the critical issues. Using this survey, we hope to identify both and share the results with you.
Our first Industry Pulse Survey focuses on the resolution of intellectual property disputes through international arbitration. In this increasingly globalized world, life sciences companies interact with their counterparts in many different countries. From product development to distribution and marketing — international collaboration encompasses virtually all aspects of your business. Results of this collaboration – patents, trademarks, commercial secrets, know-how – become valuable assets to companies. It is entirely possible that one company decides to challenge the patent, or some other intellectual property, of another. Would a court be the most appropriate place to resolve the dispute? If so, a court in which country? How do you ensure confidentiality? Ultimately, if your company is successful, how do you enforce court judgment in another country?
Arbitration provides a useful mechanism to mitigate some of these issues. International arbitral awards are recognized in 156 countries that are members of a special UN Convention. The parties are free to choose their own arbitrators, a neutral seat, and the rules of proceedings. The parties also can provide for enhanced confidentiality and security if the important trade secrets are at stake. The rules of proceedings can be modified to make the process more expeditious and cost effective.
We would like to understand the extent life sciences companies are aware of arbitration, comfortable with arbitration, and use arbitration in resolving intellectual property disputes.
We thank you beforehand for responding to the survey and look forward to sharing the results with you. If you are not directly involved with dispute resolution in your company, please feel free to forward this survey to your colleague with relevant responsibilities.
Please submit your responses by Friday, June 2, 2017.